Aurora Cannabis Cash & Equivalents Growth & History (ACB)

Aurora Cannabis's cash and equivalents was $64.7M for fiscal 2026.

View full Aurora Cannabis company overview

Aurora Cannabis annual cash and equivalents history

Aurora Cannabis annual cash and equivalents

Fiscal yearPeriod endedCash and equivalentsChangeGrowth
20262026-03-31$64.7M−$73.2M−53.10%
20252025-03-31$137.9M$1.8M+1.34%
20242024-03-31$136.1M−$119.5M−46.75%
20232023-03-31$255.6M
20222022-06-30$437.8M$16.4M+3.88%
20212021-06-30$421.5M$259.3M+159.87%
20202020-06-30$162.2M−$10.5M−6.11%
20192019-06-30$172.7M$95.9M+124.95%
20182018-06-30$76.8M

Aurora Cannabis cash and equivalents trends

Between the periods ended 2018-06-30 and 2026-03-31, Aurora Cannabis's cash and equivalents decreased from $76.8M to $64.7M, a change of −$12.1M. The latest reported quarter, Q1 2027, shows $69.3M.

About the metric

What cash and equivalents mean

Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.

Calculation and source

Reported cash and equivalents

TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Aurora Cannabis source filings ↗

Community posts

It’s quiet here.

No posts about ACB yet. Start the conversation.

Write the first post